Jeffrey Donohue

Corporate Officer/Principal at Novartis Institutes for Biomedical Research, Inc.

Consumer Services

Electronic Technology

Commercial Services

Profile

Jeffrey Donohue is currently working as a Corporate Counsel at Novartis Institutes for Biomedical Research, Inc. He previously worked as an Independent Non-Executive Director at Spectra Systems Corp.
from 2012 to 2016.
He has a graduate degree from Boston University and an undergraduate degree from Brandeis University.

Jeffrey Donohue active positions

Companies	Position	Start
Novartis Institutes for Biomedical Research, Inc. Novartis Institutes for Biomedical Research, Inc. Miscellaneous Commercial ServicesCommercial Services Novartis Institutes for Biomedical Research, Inc. conducts biomedical researches. It focuses in the areas of oncology, ophthalmology, diabetes, musculoskeletal disorders, neuroscience, and cardiovascular conditions, other focus areas include discovery chemistry, biologics, pathway biology, and translational medicine. The company was founded on September 10, 2002 and is headquartered in Cambridge, MA.	Corporate Officer/Principal	-

All active positions of Jeffrey Donohue

Former positions of Jeffrey Donohue

Companies	Position	End
SPECTRA SYSTEMS CORPORATION	Director/Board Member	2016-05-30

See the detail of Jeffrey Donohue's experience

Training of Jeffrey Donohue

Boston University	Graduate Degree
Brandeis University	Undergraduate Degree

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Jeffrey Donohue's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Listed companies	1
SPECTRA SYSTEMS CORPORATION	Electronic Technology

Private companies	1
Novartis Institutes for Biomedical Research, Inc. Novartis Institutes for Biomedical Research, Inc. Miscellaneous Commercial ServicesCommercial Services Novartis Institutes for Biomedical Research, Inc. conducts biomedical researches. It focuses in the areas of oncology, ophthalmology, diabetes, musculoskeletal disorders, neuroscience, and cardiovascular conditions, other focus areas include discovery chemistry, biologics, pathway biology, and translational medicine. The company was founded on September 10, 2002 and is headquartered in Cambridge, MA.	Commercial Services